Alinia nitazoxanide: Phase II data

Chugai, a subsidiary of Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland), has exclusive rights to develop and commercialize Alinia in Japan under a 2009 deal (see BioCentury, Feb. 23, 2009). Alinia f...